Meg Aldrich
Meg Aldrich is the director of media relations at Keck Medicine of USC. Before joining USC, she ran a media consultancy specializing in higher education and business-to-business clients for a decade. She’s a graduate of the University of Michigan, Ann Arbor and an active community volunteer.
Stories by Meg Aldrich:

Laura Mosqueda named dean of the Keck School of Medicine of USC
A widely respected expert in geriatric medicine, family medicine and elder abuse, Mosqueda is the first woman to lead the school since its founding in 1885.

U.S. News & World Report names Keck Medicine of USC hospitals among nation’s best
The magazine’s annual “Best Hospitals” rankings place Keck Medical Center of USC in California’s top 10 with five top 50 specialty rankings.

Selena Gomez donation to support lupus research at Keck School of Medicine of USC
The Selena Gomez Fund for Lupus Research backs a pilot program seeking targeted treatment of the inflammatory disease.

Experimental stem cell therapy helps paralyzed man regain use of arms and hands
The 21-year-old who suffered a cervical spine injury in March gains significant improvement in his motor function at Keck Hospital of USC.

USC program helps develop literacy for deaf and hard-of-hearing children from bilingual homes
Innovative summer program of community outreach improves reading and writing skills with interventions for students, parents and teachers.

USC and Children’s Hospital Los Angeles receive nearly $37 million grant
The National Institutes of Health award allows scientists to continue work in patient and community health.

USC Eye Institute study seeks cures to childhood myopia
Study of 9,000 Los Angeles-area children confirms global trend — the incidence of childhood myopia is increasing at an alarming pace.

USC researchers find way to improve image sharpness for blind people with retinal implants
Increasing the duration of stimulus pulses allows visualization of distinct focal spots of light.
Promising USC study focuses on treatment for dry eyes
A natural protein in tears could help researchers looking at the common affliction.